Global L-Phenylalanine Market Size Estimated to Reach $432 Million by 2027
Research Reports
Apr 08, 2022
Global L-Phenylalanine Market size is estimated to reach $432 million by 2027, growing at a CAGR of 3.3% during the forecast period 2022-2027. L-Phenylalanine is commonly delineated as a vital amino acid that amalgamates to form proteins. Phenylalanine is generally of two types; the first one (L-Phenylalanine) naturally originates from the foods like meat, egg, fish, lentils, and dairy items, and the following one (D-Phenylalanine) is fabricated unnaturally in medical facilities and sold as a dietary supplement. In order to detect the existence of proteins and amino acids in unfamiliar samples laboratories frequently perform ninhydrin tests. This amino acid plays a crucial role in the production of dopamine, therefore, supporting relieving depression. It has far-ranging applications from enhancing one’s mood to a healthier skin appearance. However, phenylalanine can be dangerous in treating patients suffering from complications such as phenylketonuria, alkaptonuria, albinium, which occurs owing to deficiency of homogentisic acid oxidase and excess phenylalanine. These conditions neutralize the ability of the body to metabolize phenylalanine which leads to excessive coagulation. The Global L-Phenylalanine market outlook seems fairly astonishing as aesthetic consciousness among people has accrued up a notch in recent years. Arthritis incidences have come to the forefront in recent years as the percentage of elderly people is on the rise. Moreover, the proliferating prevalence of attention deficit hyperactivity disorder (ADHD), depression, and skin disorders like vitiligo are factors set to drive the growth of the Global L-Phenylalanine industry for the period 2022-2027.
Global L-Phenylalanine Market Segment Analysis – By Application
The Global L-Phenylalanine Market based on the application type can be further segmented into chronic/long-lasting pain, skin conditions (vitiligo), stress and depression, alcohol withdrawal indications, joint disorders (rheumatoid arthritis, osteoarthritis), attention deficit-hyperactivity disorder (ADHD), and others. The chronic pain and joint disorders segment held the largest share in 2021. The growth is owing to the heightening prevalence of joint disorder and chronic pain incidences. Dwindling immunity and soaring old-age population are the preeminent factors behind such complications. According to a report based on NHIS data, around 50.2 million people in the U.S. experienced chronic pain in 2021. The mentioned figure is likely to upsurge in of foreseeable future as incidences of diabetes and road tragedies are augmenting. on another hand, enlarging cancer survival rates have their fair share in spiking the overall occurrence of chronic pain as cancer treatments bring patients to bear heavy mental and physical torture. Around 30%-60% of od survivors are left with lifelong physical pain. Nevertheless, the depression and joint-disorders segment are estimated to be the fastest-growing segment with a CAGR of 3.5% over the forecast period 2022-2027. This growth is owing to shooting up cases of depressive disorders and joint complications. Sky-rocketing inflation, widescale unemployment, hectic work life, and constant starvation for being perfect are prime reasons behind the sliding of many people especially millennials into depression. On another hand, broadening joint disorders cases are attributing prolonged sittings and plunging old-age population throughout the globe.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=513378
Report Price: $ 5900 (Single User License)
Global L-Phenylalanine Market Segment Analysis – By Distribution Channel
The Global L-Phenylalanine Market based on distribution channels can be further segmented into hospital pharmacies, community pharmacies, and online platforms. The hospital and community pharmacy segment held the largest share in 2021. The growth is owing to heavy sales as complications such as depression, arthritis, skin problems, and chronic illnesses are on a loose. No one begrudges even a single penny spent on healthcare, therefore, expanding health awareness among people encouraging them to undergo required treatments and medications. Besides, retail pharmacies extend the option of making over-the-counter purchases that do not require a prior prescription from medical practitioners. Moreover, the far-reaching presence of these physical facilities in both developed and impoverished areas is acting as a significant driver in the growth of the segment. Furthermore, the online platforms segment is estimated to be the fastest-growing segment with a CAGR of 4.6% over the forecast period 2022-2027. This growth is owing to a rising tech-friendly population. For instance, out of 1.4 billion people, around 622 million falls under the category of active internet users and includes user from both cities and the countryside. Moreover, COVID-19 restrictions are a blessing in disguise for the segment as they drive people one step closer to making online purchases.
Global L-Phenylalanine Market Segment Analysis – By Geography
The Global L-Phenylalanine Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America segment held the largest share with 39% of the overall market in 2021. The growth in this segment is owing to the factors such as the presence of the health-conscious public. Besides, the heavy spread of cancer and the high recovery rate is attributed to advance technologies and well-established healthcare infrastructure. Besides cancer, osteoarthritis is roaming around in countries like the U.S. as over 50 million US adults were afflicted with this complication in 2021. On another hand, depression is a big issue in the U.S. Last November, approximately 4 million US workers resigned from their job most of which are owing to tormenting personal and work-life balance. However, Asia-pacific is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to proliferating levels of anxiety and depression among residents. Asia is home to more than 50% of the world population, with India and China being the most populous countries. Humungous population brings enormous competition with it and eventually forces millions of people into depression. Also, rising old age is resulting in heightened incidences of chronic pain and joint abnormalities. Likewise, soaring economic affluence is changing people living standards, therefore, they are more cognizant regarding their appearance and health.
Global L-Phenylalanine Market Drivers
Skin problems and other health illnesses are anticipated to boost product demand
Phenylalanine in combination with ultraviolet light (UVA) is deemed to be a potential treatment for skin disorders like vitiligo through repigmentation or depigmentation. Even though the occurrence of this problem is rare as it affects only 0.5-1% of the world population, however, shifting attitudes of people from treatment to prevention is acting as a significant driver for the l-phenylalanine market. On another hand, the surging prevalence of chronic illnesses is providing a platform for the growth of the market as l-phenylalanine plays a crucial role in the treatment of chronic pain and joint disorders. More than 350 million people across the globe has arthritis in 2021. The figure is likely to proliferate as the elderly population is expected to touch 2 billion before long.
Budding depressive disorders is expected to boost product demand
Depressive disorders have come to the foreground in recent years like never before. There are several factors behind the sky-rocketing prevalence of depression such as low self-esteem, disrupted work and personal life balance, inherited, and many more. However, events over the years such as COVID-19 have heightened the overall incidences as millions of people have developed health complications, lost their jobs, and their loved ones in the time span of the last 2 years. According to a World Health Organization (WHO) report, around 5% of adults throughout the globe are hurt from mental disorders and over 700,000 people commit suicide owing to mental pressure.
Inquiry Before Buying @ https://www.industryarc.com/reports/request-quote?id=513378
Global L-Phenylalanine Market Challenges
Side-effects associated with L-Phenylalanine and disrupted supply chain are anticipated to hamper the market growth
Even though l-phenylalanine is of utmost importance as it helps in the production of dopamine and makes individuals feel pleasure people’s health may fall victim to it as it is of addictive nature. Its overuse can set many complications like constipation, hypomania, heartburn, sedation, and others in motion. Moreover, such amino acids lead to an excess of chemicals like tyramine in the body which eventually increase blood pressure. Besides health hitches, the disrupted supply chains attributed to the COVID-19 erupting many challenges for the manufacturers.
Global L-Phenylalanine Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the market. Global L-Phenylalanine top 10 companies include:
Now Foods
NutraMarks
LiftMode
Amazing Nutrition
Jirong Pharmaceutical
Ajinomoto
Kyowa Hakko Bio
AMINO
Livzon Pharmaceutical group
Wuxi Jinghai Amino Acid Co.
Recent Developments
On July 21, 2021, Ajinomoto launched a supplement “Nou-Katsu seven amino” which contain seven amino acids that primarily include Phenylalanine and can be used to reduce the risk of cognitive decline in middle-aged or elderly people experiencing some sort of memory disorders.
On September 16, 2019, Illinois, United States-based company “Now Foods” which offers various sports nutrition products and dietary supplements announced the successful acquisition of Canada-based vitamin manufacturer “SuperNutrition” to enhance its existing portfolio. The financial details of the transaction were not disclosed by the company.
On August 22, 2019, Japanese food and biotechnology company “Ajinomoto” announced the successful acquisition of Ohio, United States-based food manufacturing company “More Than Gourmet.” In the acquisition, Ajinomoto acquired more than fifty percent stake for an undisclosed price. Moreover, the acquisition is anticipated to expand the food solution portfolio of Ajinomoto in the North American continent.
Direct Purchase @ https://www.industryarc.com/purchasereport.php?id=513378
Key Takeaways
Geographically, the North America L-Phenylalanine Market accounted for the highest revenue share in 2021. Nevertheless, Asia-pacific is poised to dominate the market over the period 2022-2027.
Heightening demand with soaring depression, joint disorders, and skin problems are said to be preeminent drivers driving the growth of the Global L-Phenylalanine Market. Health complication linked with overuse and disrupted supply chain owing to virus outbreak is said to reduce the market growth.
Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Global L-Phenylalanine Market report.
Relevant Reports:
A. Protein and Amino Acids Market
https://www.industryarc.com/Report/7454/protein-amino-acids-market.html
B. Food Amino Acids Market
https://www.industryarc.com/Research/Food-Amino-Acids-Market-Research-504630
For more Food and Beverage Market reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
Contact Information:
Venkat Reddy Sales Director Email: venkat@industryarc.com Website: https://www.industryarc.com Phone: (+1) 970-236-3677
Tags:
Reportedtimes, PR-Wirein, Extended Distribution, Research Newswire, English